Mirae Asset Global Investments’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Mirae Asset Global Investments's ADPT Position: Q2 2026 in Review
Mirae Asset Global Investments reduced its Adaptive Biotechnologies (ADPT) stake by 11% in Q2 2026, selling an estimated $13.4K and leaving 7,158 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #1163.
Mirae Asset Global Investments first reported a position in ADPT in Q3 2019 and has held it in 18 quarters since. The position peaked at $5.18M in Q3 2019. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.
- Mirae Asset Global Investments held 7,158 shares of Adaptive Biotechnologies worth $154K as of Q2 2026.
- Mirae Asset Global Investments sold 874 Adaptive Biotechnologies shares in Q2 2026, an estimated $13.4K.
- Adaptive Biotechnologies made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1163 holding.
- Mirae Asset Global Investments first reported a position in Adaptive Biotechnologies in Q3 2019 and has held it in 18 quarters since.
- Mirae Asset Global Investments's Adaptive Biotechnologies position peaked at $5.18M in Q3 2019.
- 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.
Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.